CNTB Connect Biopharma Holdings Limited - Ordinary Shares
$2,54
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$1–$4
51% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$7
+185% upside
P/E (TTM)
-2.8
ROE
-97.9%
Nettogewinnmarge
-86687.5%
CNTB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.54
Marktkapitalisierung
$159M
P/E (TTM)
-2.8
EPS (TTM)
$-1.00
Umsatz (TTM)
$64.0K
Dividendenrendite
—
ROE
-97.9%
Verschuldungsgrad
—
52W-Spanne
$1 – $4
CNTB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$64.0K
2023-12-31
→
2025-12-31
EPS
$-1.00
2023-12-31
→
2025-12-31
Freier Cashflow
$-52M
2024-12-31
→
2025-12-31
Margen
-86687.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CNTB
Peer-Median
P/E (TTM)
-2.8
1.2
P/S (TTM) (K/V (TTM))
2488.9
14.2
P/B (K/B)
3.8
1.2
Price / FCF (Kurs / FCF)
-3.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CNTB
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-90740.6%
—
Net Profit Margin (Nettogewinnmarge)
-86687.5%
-1189.1%
ROA
-70.5%
-58.9%
ROE
-97.9%
-79.0%
ROIC
-138.8%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CNTB
Peer-Median
Current Ratio (Liquiditätsgrad)
3.7
5.4
Quick Ratio
3.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CNTB
Peer-Median
Revenue YoY (Umsatz YoY)
-99.8%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CNTB
Peer-Median
CNTB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 5 35,7%
- Kauf 8 57,1%
- Halten 1 7,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-17
Median
$7.00
← Unter allen Zielen
$2.54
Tief
$4.00
Hoch
$10.00
Median-Ziel
$7.00
+175,6%
Mittelwert-Ziel
$7.25
+185,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.0%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.34 | $-0.23 | -0.11% |
| 31. Dezember 2025 | $-0.27 | $-0.21 | -0.06% |
| 30. September 2025 | $-0.31 | $-1.01 | 0.70% |
| 30. Juni 2025 | $-0.23 | $-0.92 | 0.69% |
| 31. März 2025 | $-0.19 | $-1.92 | 1.7% |
| 30. Juni 2023 | $-3.90 | $-7.07 | 3.2% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| HUMA | — | — | — | — | — | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| HURA | — | -1.2 | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $64.0K | $26M | $0 | |
| R&D Expense | $38M | $29M | $53M | |
| SG&A Expense | $20M | $19M | $16M | |
| Operating Expenses | $58M | $48M | $69M | |
| Operating Income | $-58M | $-22M | $-69M | |
| Other Non-op | $523.0K | $3M | $2M | |
| Pretax Income | $-55M | $-15M | $-62M | |
| Income Tax | $197.0K | $223.0K | $120.0K | |
| Net Income | $-55M | $-16M | $-62M | |
| EPS (Basic) | $-1.00 | $-0.28 | $-1.13 | |
| EPS (Diluted) | $-1.00 | $-0.28 | $-1.13 | |
| Shares (Basic) | 55,660,000 | 55,213,000 | 55,067,000 | |
| Shares (Diluted) | 55,660,000 | 55,213,000 | 55,067,000 | |
| EBITDA | $-57M | $-22M | · |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $38M | $78M | $106M | |
| Short-term Investments | $6M | $15M | $13M | |
| Receivables | $13.0K | $789.0K | $0 | |
| Prepaid Expense | $7M | $2M | $4M | |
| Other Current Assets | · | $53.0K | $54.0K | |
| Current Assets | $51M | $97M | $123M | |
| PP&E (Net) | $4M | $4M | $4M | |
| PP&E (Gross) | $7M | $7M | $6M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Intangibles | $45.0K | $53.0K | $62.0K | |
| Other Non-current Assets | $646.0K | $33.0K | $24.0K | |
| Total Assets | $56M | $101M | $127M | |
| Accounts Payable | $2M | $342.0K | $2M | |
| Accrued Liabilities | $11M | $8M | $9M | |
| Current Liabilities | $14M | $8M | $25M | |
| Capital Leases | $368.0K | $24.0K | $180.0K | |
| Other Non-current Liabilities | $114.0K | $632.0K | · | |
| Total Liabilities | $14M | $9M | $26M | |
| Common Stock | $10.0K | $10.0K | $10.0K | |
| Paid-in Capital | $444M | $439M | $432M | |
| Retained Earnings | $-401M | $-345M | $-330M | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | |
| AOCI | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $42M | $92M | $101M | |
| Liabilities + Equity | $56M | $101M | $127M | |
| Shares Outstanding | 56,442,308 | 55,349,000 | 55,103,000 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $704.0K | $660.0K | $720.0K | |
| Stock-based Comp | $4M | $7M | $5M | |
| Restructuring | · | $3M | · | |
| Other Non-cash | $-156.0K | $-15M | · | |
| Operating Cash Flow | $-51M | $-24M | $-48M | |
| CapEx | $434.0K | $750.0K | $81.0K | |
| Investing Cash Flow | $10M | $-3M | $75M | |
| Financing Cash Flow | $1M | $227.0K | $45.0K | |
| Net Change in Cash | $-40M | $-27M | $27M | |
| Taxes Paid | · | $111.0K | $120.0K | |
| Free Cash Flow | $-52M | $-24M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -90740.6% | -86.2% | · | |
| Net Margin | -86687.5% | -60.0% | · | |
| Pretax Margin | -86379.7% | -59.2% | · | |
| EBITDA Margin | -89640.6% | -83.7% | · | |
| ROA | -70.5% | -13.7% | · | |
| ROE | -97.9% | -16.2% | · | |
| ROIC | -138.8% | -24.7% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.7 | 11.5 | · | |
| Quick Ratio | 3.3 | 11.2 | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | |
| Receivables Turnover | 0.2 | 66.0 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -99.8% | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $64.0K | $26M | · | |
| Net Income TTM | $-55M | $-16M | · | |
| Market Cap | $159M | $76M | · | |
| P/E | -2.8 | -4.9 | · | |
| P/S | 2487.0 | 2.9 | · | |
| P/B | 3.8 | 0.8 | · | |
| P / Tangible Book | 3.8 | 0.8 | · | |
| P / Cash Flow | -3.1 | -3.2 | · | |
| P / FCF | -3.1 | -3.1 | · | |
| Earnings Yield | -35.5% | -20.3% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $169.0K | $0 | $16.0K | $48.0K | $0 | $698.0K | $1M | $24M | |
| R&D Expense | $16M | $15M | $11M | $11M | $9M | $7M | $6M | $9M | $5M | |
| SG&A Expense | $4M | $5M | $4M | $7M | $5M | $5M | $4M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $16M | $18M | $13M | $11M | $10M | $15M | $10M | |
| Operating Income | $-18M | $-20M | $-16M | $-18M | $-13M | $-11M | $-10M | $-14M | $14M | |
| Other Non-op | $67.0K | $-3.0K | $60.0K | $-7.0K | $-39.0K | $509.0K | $-30.0K | $-108.0K | $9.0K | |
| Pretax Income | $-17M | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| Income Tax | $60.0K | $48.0K | $27.0K | $61.0K | $55.0K | $54.0K | $106.0K | $57.0K | $30.0K | |
| Net Income | $-17M | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| EPS (Basic) | $-0.27 | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| EPS (Diluted) | $-0.27 | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| Shares (Basic) | 62,884,000 | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,330,000 | 55,254,000 | 55,186,000 | |
| Shares (Diluted) | 62,884,000 | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,854,000 | 55,254,000 | 55,710,000 | |
| EBITDA | $-18M | $-19M | · | $-18M | $-13M | $-11M | · | · | · |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $46M | $38M | $38M | $41M | $48M | $78M | · | · | |
| Short-term Investments | $4M | $0 | $6M | $17M | $31M | $36M | $15M | · | · | |
| Receivables | $3M | $0 | $13.0K | $17.0K | $0 | $8.0K | $789.0K | · | · | |
| Prepaid Expense | $4M | $9M | $7M | $8M | $6M | $4M | $2M | · | · | |
| Other Current Assets | · | · | · | · | $228.0K | $65.0K | · | · | · | |
| Current Assets | $39M | $55M | $51M | $63M | $78M | $88M | $97M | · | · | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | · | |
| PP&E (Gross) | · | · | $7M | · | · | · | $7M | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | |
| Intangibles | $42.0K | $43.0K | $45.0K | $47.0K | $48.0K | $50.0K | $53.0K | · | · | |
| Other Non-current Assets | $646.0K | $646.0K | $646.0K | $45.0K | $45.0K | $45.0K | $33.0K | · | · | |
| Total Assets | $43M | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Accounts Payable | $2M | $4M | $2M | $2M | $2M | $817.0K | $342.0K | · | · | |
| Accrued Liabilities | $14M | $12M | $11M | $9M | $8M | $7M | $8M | · | · | |
| Current Liabilities | $16M | $17M | $14M | $11M | $11M | $9M | $8M | · | · | |
| Capital Leases | $203.0K | $287.0K | $368.0K | $445.0K | $520.0K | $594.0K | $24.0K | · | · | |
| Other Non-current Liabilities | $107.0K | $111.0K | $114.0K | $118.0K | $122.0K | $627.0K | $632.0K | · | · | |
| Total Liabilities | $17M | $17M | $14M | $12M | $11M | $10M | $9M | · | · | |
| Common Stock | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | · | · | |
| Paid-in Capital | $466M | $464M | $444M | $443M | $441M | $440M | $439M | · | · | |
| Retained Earnings | $-438M | $-420M | $-401M | $-386M | $-369M | $-356M | $-345M | · | · | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | · | · | |
| AOCI | $-962.0K | $-1M | $-1M | $-1M | $-1M | $-2M | $-2M | · | · | |
| Stockholders' Equity | $27M | $43M | $42M | $55M | $71M | $83M | $92M | · | · | |
| Liabilities + Equity | $43M | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Shares Outstanding | 62,974,309 | 62,711,690 | 56,442,308 | 55,786,000 | 55,580,000 | 55,352,000 | 55,349,208 | · | · |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $161.0K | $164.0K | $181.0K | $179.0K | $171.0K | $173.0K | $158.0K | $176.0K | $162.0K | |
| Stock-based Comp | $1M | $1M | $917.0K | $916.0K | $951.0K | $942.0K | $1M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | $0 | $2M | $1M | |
| Other Non-cash | · | $2M | · | · | · | $-802.0K | · | · | · | |
| Operating Cash Flow | $-16M | $-16M | $-11M | $-17M | $-13M | $-10M | $-2M | $-13M | $-8M | |
| CapEx | $0 | $0 | $16.0K | $34.0K | $303.0K | $81.0K | $313.0K | $147.0K | $290.0K | |
| Investing Cash Flow | $-4M | $6M | $11M | $14M | $5M | $-21M | $-16M | $-147.0K | $3M | |
| Stock Issued | $0 | $137.0K | · | · | $18.0K | $2.0K | · | · | · | |
| Net Stock Activity | · | $137.0K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $18M | $715.0K | $215.0K | $161.0K | $2.0K | $106.0K | $0 | $121.0K | |
| Net Change in Cash | $-19M | $8M | $500.0K | $-3M | $-7M | $-31M | $-19M | $-13M | $-4M | |
| Taxes Paid | · | · | · | $0 | · | · | · | $111.0K | · | |
| Free Cash Flow | · | $-16M | · | · | · | $-10M | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -636.0% | -11601.8% | · | -110481.2% | -27966.7% | · | · | · | · | |
| Net Margin | -624.4% | -11478.1% | · | -107500.0% | -26872.9% | · | · | · | · | |
| Pretax Margin | -622.2% | -11449.7% | · | -107118.8% | -26758.3% | · | · | · | · | |
| EBITDA Margin | -636.0% | -11504.7% | · | -110481.2% | -27966.7% | · | · | · | · | |
| ROA | -27.4% | -25.4% | · | -51.1% | -31.2% | -22.2% | · | · | · | |
| ROE | -35.2% | -30.9% | · | -62.1% | -36.2% | -24.8% | · | · | · | |
| ROIC | -65.8% | -46.1% | · | -32.0% | -18.9% | -13.9% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 3.2 | · | 5.5 | 7.2 | 10.2 | · | · | · | |
| Quick Ratio | 2.1 | 2.7 | · | 4.8 | 6.7 | 9.8 | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 1.9 | 42.2 | · | 1.9 | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $233.0K | · | · | · | · | · | · | · | |
| Net Income TTM | $-67M | $-60M | · | $-53M | $-21M | $-17M | · | · | · | |
| Market Cap | $150M | $164M | · | $84M | $54M | $30M | · | · | · | |
| P/E | -2.1 | -2.4 | · | -1.6 | -2.6 | -1.8 | · | · | · | |
| P/S | 49.9 | 705.2 | · | · | · | · | · | · | · | |
| P/B | 5.6 | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Tangible Book | 5.6 | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Cash Flow | · | -10.3 | · | · | · | -3.1 | · | · | · | |
| P / FCF | · | -10.3 | · | · | · | -3.0 | · | · | · | |
| Earnings Yield | -48.3% | -40.8% | · | -63.6% | -38.8% | -56.4% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $64.0K | $26M | $0 |
| Betriebsgewinnmarge % | -90740.6% | -86.2% | — |
| Nettoergebnis | $-55M | $-16M | $-62M |
| Verwässerte EPS | $-1.00 | $-0.28 | $-1.13 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 3.7 | 11.5 | — |
| Quick Ratio | 3.3 | 11.2 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-52M | $-24M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 56 Einreicher · $29.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 24 (+4 vs. Vorquartal) | 9 (+6 vs. Vorquartal) | 14 (+7 vs. Vorquartal) | 11 (+4 vs. Vorquartal) | -260K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Ikarian Capital, LLC | $10.801.710 | 4.538.534 | 36,96% | Aktien |
| 683 Capital Management, LLC | $3.058.300 | 1.285.000 | 10,46% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.317.482 | 973.732 | 7,93% | Aktien |
| PERCEPTIVE ADVISORS LLC | $1.886.616 | 792.696 | 6,45% | Aktien |
| ADAR1 Capital Management, LLC | $1.666.000 | 700.000 | 5,70% | Aktien |
| BML Capital Management, LLC | $1.364.423 | 573.287 | 4,67% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.297.100 | 545.000 | 4,44% | Aktien |
| Knott David M Jr | $1.058.772 | 444.862 | 3,62% | Aktien |
| Stonepine Capital Management, LLC | $866.925 | 364.254 | 2,97% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $561.099 | 235.756 | 1,92% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $474.527 | 199.381 | 1,62% | Aktien |
| DIADEMA PARTNERS LP | $468.824 | 196.985 | 1,60% | Aktien |
| MARSHALL WACE, LLP | $388.341 | 163.168 | 1,33% | Aktien |
| Burkehill Global Management, LP | $357.000 | 150.000 | 1,22% | Aktien |
| Richmond Brothers, Inc. | $334.169 | 140.408 | 1,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $244.557 | 102.755 | 0,84% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $243.112 | 102.148 | 0,83% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $207.774 | 87.300 | 0,71% | Aktien |
| SIMPLEX TRADING, LLC | $195.036 | 81.948 | 0,67% | Aktien |
| STATE STREET CORP | $158.746 | 66.700 | 0,54% | Aktien |
| UBS Group AG | $158.153 | 66.451 | 0,54% | Aktien |
| Persistent Asset Partners Ltd | $118.698 | 49.873 | 0,41% | Aktien |
| Koa Wealth Management, LLC | $118.048 | 49.600 | 0,40% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $115.192 | 48.400 | 0,39% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $104.025 | 43.708 | 0,36% | Aktien |
| BANK OF AMERICA CORP /DE/ | $97.390 | 40.920 | 0,33% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $87.489 | 36.760 | 0,30% | Aktien |
| XTX Topco Ltd | $68.208 | 28.659 | 0,23% | Aktien |
| Bank of New York Mellon Corp | $57.006 | 23.952 | 0,20% | Aktien |
| Nuveen, LLC | $47.060 | 19.773 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $43.554 | 18.300 | 0,15% | Verkaufsoption |
| Y-Intercept (Hong Kong) Ltd | $35.864 | 15.069 | 0,12% | Aktien |
| WELLS FARGO & COMPANY/MN | $31.511 | 13.240 | 0,11% | Aktien |
| SmartHarvest Portfolios, LLC | $30.695 | 12.897 | 0,11% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $26.927 | 11.314 | 0,09% | Aktien |
| MONOGRAPH WEALTH ADVISORS, LLC | $26.489 | 11.130 | 0,09% | Aktien |
| RHUMBLINE ADVISERS | $26.124 | 10.979 | 0,09% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $16.432 | 6.904 | 0,06% | Aktien |
| JPMORGAN CHASE & CO | $14.794 | 6.216 | 0,05% | Aktien |
| CITIGROUP INC | $14.568 | 6.121 | 0,05% | Aktien |
| Legal & General Group Plc | $5.748 | 2.415 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $5.693 | 2.392 | 0,02% | Aktien |
| MORGAN STANLEY | $5.622 | 2.362 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $5.450 | 2.290 | 0,02% | Aktien |
| BARCLAYS PLC | $4.698 | 1.974 | 0,02% | Aktien |
| Russell Investments Group, Ltd. | $2.844 | 1.195 | 0,01% | Aktien |
| BlackRock, Inc. | $2.509 | 1.054 | 0,01% | Aktien |
| HUNTINGTON NATIONAL BANK | $2.370 | 996 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $2.099 | 882 | 0,01% | Aktien |
| ROYAL BANK OF CANADA | $1.000 | 540 | 0,00% | Aktien |
| FMR LLC | $747 | 314 | 0,00% | Aktien |
| Sterling Capital Management LLC | $357 | 150 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $157 | 66 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $30 | 12.469 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $14 | 6 | 0,00% | Aktien |
| FNY Investment Advisers, LLC | $11 | 5.000 | 0,00% | Aktien |
Unternehmensinsider 3 Insider · 0 Führungskräfte · 3 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kleanthis Gabriel Xanthopoulos | Direktor | 30. Juni 2026 A | 86.554 | 0 | 0 | $0 |
| Jean I Liu | Direktor | 30. Juni 2026 A | 11.779 | 0 | 0 | $0 |
| James Huang | Direktor | 29. Mai 2026 P | 13.310.000 | 2 | 0 | $4.374.000 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., James Huang ×6 Einreichungen | 1. April 2026 | 21,20% | Änderung | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×6 Einreichungen | 27. Februar 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 6 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 50.108 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 370.406 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 376.234 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 86.692 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.283 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.780 SH | 8. August 2026 | Täglich |